Chronic News and Research

RSS
Study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

Study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

People living with HIV in rural communities may face different barriers to taking proper care of themselves

People living with HIV in rural communities may face different barriers to taking proper care of themselves

A new marker for osteoarthritis

A new marker for osteoarthritis

First evidence of the molecular link between inflammation and cancer

First evidence of the molecular link between inflammation and cancer

Rheumatoid arthritis and early indicators of disease

Rheumatoid arthritis and early indicators of disease

24-year long asthma study is answering doctors' questions about asthma and its causes

24-year long asthma study is answering doctors' questions about asthma and its causes

Current estimates have cardiovascular disease (CVD) accounting for 17 million deaths annually

Current estimates have cardiovascular disease (CVD) accounting for 17 million deaths annually

New clinical study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

New clinical study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

Coping programs for adolescent children of HIV-infected parents help teens develop into productive young adults

Coping programs for adolescent children of HIV-infected parents help teens develop into productive young adults

Mothers who catch a flu during pregnancy may increase the risk of their child developing schizophrenia

Mothers who catch a flu during pregnancy may increase the risk of their child developing schizophrenia

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

Aventis ships its influenza vaccine, Fluzone

Aventis ships its influenza vaccine, Fluzone

FDA has granted orphan drug designation to Myogen's ambrisentan, for the treatment of pulmonary arterial hypertension

FDA has granted orphan drug designation to Myogen's ambrisentan, for the treatment of pulmonary arterial hypertension

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Connection between air pollution and cardiovascular disease

Connection between air pollution and cardiovascular disease

European recommended approval of Remicade for treatment of psoriatic arthritis

European recommended approval of Remicade for treatment of psoriatic arthritis

Researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS

Researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS

Clinical benefit for moderate-to-severe plaque psoriasis patients treated with Raptiva for 30 months

Clinical benefit for moderate-to-severe plaque psoriasis patients treated with Raptiva for 30 months

Negative side effects of iron for people with kidney disease

Negative side effects of iron for people with kidney disease

Automated health databases can help physicians monitor chronic diseases like hypertension

Automated health databases can help physicians monitor chronic diseases like hypertension

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.